Cyanopindolol

Chemical compound
  • none
Identifiers
  • (RS)-4-[3-(tert-Butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile
CAS Number
  • 69906-85-0 checkY
PubChem CID
  • 155346
IUPHAR/BPS
  • 132
ChemSpider
  • 136847 ☒N
UNII
  • 4K0SD5SNFS
ChEMBL
  • ChEMBL378501 ☒N
PDB ligand
  • P32 (PDBe, RCSB PDB)
Chemical and physical dataFormulaC16H21N3O2Molar mass287.363 g·mol−13D model (JSmol)
  • Interactive image
ChiralityRacemic mixture
  • N#CC1=CC2=C(OCC(CNC(C)(C)C)O)C=CC=C2N1
InChI
  • InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-7,12,18-20H,9-10H2,1-3H3 ☒N
  • Key:QXIUMMLTJVHILT-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Cyanopindolol is a drug related to pindolol which acts as both a β1 adrenoceptor antagonist and a 5-HT1A receptor antagonist. Its radiolabelled derivative iodocyanopindolol has been widely used in mapping the distribution of beta adrenoreceptors in the body.[1]

References

  1. ^ Hoyer D, Engel G (1983). "Binding of 125I-cyanopindolol to beta-1-adrenoceptors in a high and low affinity state". Journal of Receptor Research. 3 (1–2): 45–59. doi:10.3109/10799898309041922. PMID 6304308.
  • v
  • t
  • e
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e